Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lamotrigine 70mg/5ml oral suspension
0408010H0AABVBV
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamprene 100mg capsules
0501100C0BBAAAA
|
Lamprene | Clofazimine | Infections | No data available |
|
Lamprene 50mg capsules
0501100C0BBACAC
|
Lamprene | Clofazimine | Infections | No data available |
|
Lanacane 3% cream
1303000B0BCAAAF
|
Lanacane | Benzocaine | Skin | No data available |
|
Lanacane medicated powder
130203000BRAQA0
|
Proprietary compound preparation BNF 1302030 | Other dusting powder preparations | Skin | No data available |
|
Lanacort 1% cream
1304000X0BEAAAA
|
Lanacort | Hydrocortisone acetate | Skin | No data available |
|
Lanacort 1% ointment
1304000X0BEABBA
|
Lanacort | Hydrocortisone acetate | Skin | No data available |
|
Lanes Modern Herbals Laxative tablets
010602000BBBIA0
|
Proprietary compound preparation BNF 0106020 | Other stimulant laxative preparations | Gastro-Intestinal System | No data available |
|
Lanoxin 500micrograms/2ml solution for infusion ampoules
0201010F0BBACAC
|
Lanoxin | Digoxin | Cardiovascular System | No data available |
|
Lanoxin Injection Pediatric 100micrograms/1ml inj ampoules
0201010F0BBAGAR
|
Lanoxin | Digoxin | Cardiovascular System | No data available |
|
Lanreotide 60mg/0.3ml inj pre-filled syringes
0803043P0AAABAB
|
Lanreotide | Lanreotide | Malignant Disease and Immunosuppression | No data available |
|
Lanreotide 90mg/0.3ml inj pre-filled syringes
0803043P0AAACAC
|
Lanreotide | Lanreotide | Malignant Disease and Immunosuppression | No data available |
|
Lansoprazole 10mg oral powder sachets
0103050L0AAARAR
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 11mg/5ml oral liquid
0103050L0AAAUAU
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 15mg oral powder sachets
0103050L0AABBBB
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 20mg/5ml oral liquid
0103050L0AAASAS
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 22.5mg/5ml oral suspension
0103050L0AABABA
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 22mg/5ml oral liquid
0103050L0AAAVAV
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 3.75mg/5ml oral solution
0103050L0AABDBD
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 30mg gastro-resistant granules sachets
0103050L0AAADAD
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 3mg/5ml oral liquid
0103050L0AAAKAK
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 40mg/5ml oral liquid
0103050L0AAATAT
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 4mg/5ml oral liquid
0103050L0AAAPAP
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 50mg/5ml oral suspension
0103050L0AAAWAW
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 5mg/5ml oral solution
0103050L0AAAQAQ
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.